Myken, PS, Bech‐Hansen, O. A 20‐year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009, 137:76–81.
Schoen, FJ, Levy, RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999, 47:439–465.
Schoen, FJ, Levy, RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005, 79:1072–1080.
Sacks, MS, Schoen, FJ, Mayer, JE. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 2009, 11:289–313.
El Oakley, R, Kleine, P, Bach, DS. Choice of prosthetic heart valve in today`s practice. Circulation 2008, 117:253–256.
Driessen‐Mol, A, Emmert, MY, Dijkman, PE, Frese, L, Sanders, B, Weber, B, Cesarovic, N, Sidler, M, Leenders, J, Jenni, R, et al. Transcatheter implantation of homologous "off‐the‐shelf" tissue‐engineered heart valves with self‐repair capacity: long‐term functionality and rapid in vivo remodeling in sheep. J Am Coll Cardiol 2014, 63:1320–1329.
Stradins, P, Lacis, R, Ozolanta, I, Purina, B, Ose, V, Feldmane, L, Kasyanov, V. Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg 2004, 26:634–639.
Sacks, MS, Yoganathan, AP. Heart valve function: a biomechanical perspective. Philos Trans R Soc Lond B Biol Sci 2007, 362:1369–1391.
Balguid, A, Rubbens, MP, Mol, A, Bank, RA, Bogers, AJJC, van Kats, JP, de Mol, BAJM, Baaijens, FPT, Bouten, CVC. The role of collagen cross‐links in biomechanical behavior of human aortic heart valve leaflets‐relevance for tissue engineering. Tissue Eng 2007, 13:1501–1511.
Gould, ST, Srigunapalan, S, Simmons, CA, Anseth, KS. Hemodynamic and cellular response feedback in calcific aortic valve disease. Circ Res 2013, 113:186–197.
Chester, AH, Taylor, PM. Molecular and functional characteristics of heart‐valve interstitial cells. Philos Trans R Soc Lond B Biol Sci 2007, 362:1437–1443.
Chen, JH, Yip, CY, Sone, ED, Simmons, CA. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 2009, 174:1109–1119.
Rabkin‐Aikawa, E, Mayer, JE, Schoen, FJ. Heart valve regeneration. Adv Biochem Eng Biotechnol 2005, 94:141–179.
Aikawa, E, Whittaker, P, Farber, M, Mendelson, K, Padera, RF, Aikawa, M, Schoen, FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344–1352.
Winer, JP, Janmey, PA, McCormick, ME, Funaki, M. Bone marrow‐derived mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A 2009, 15:147–156.
Butcher, JT, Mahler, GJ, Hockaday, LA. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev 2011, 63:242–268.
Mol, A, Driessen, NJ, Rutten, MC, Hoerstrup, SP, Bouten, CV, Baaijens, FP. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain‐based conditioning approach. Ann Biomed Eng 2005, 33:1778–1788.
Balguid, A, Mol, A, van Vlimmeren, MA, Baaijens, FP, Bouten, CV. Hypoxia induces near‐native mechanical properties in engineered heart valve tissue. Circulation 2009, 119:290–297.
Stock, UA, Nagashima, M, Khalil, PH, Nollert, GD, Herden, T, Sperling, JS, Moran, A, Lien, J, Martin, DP, Schoen, FJ, et al. Tissue‐engineered valve conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000, 119:732–740.
Appleton, AJE, Appleton, TG, Boughner, DR, Rogers, KA. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering. Tissue Eng Part A 2009, 15:3889–3897.
Simpson, DL, Wehman, B, Galat, Y, Sharma, S, Mishra, R, Galat, V, Kaushal, S. Engineering patient‐specific valves using stem cells generated from skin biopsy specimens. Ann Thorac Surg 2014, 98:947–954.
Hoerstrup, S, Sodian, R, Daebritz, S, Wang, J, Bacha, EA, Martin, DP, Moran, AM, Guleserian, KJ, Sperling, JS, Kaushal, S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000, 102:44–49.
Eckert, CE, Mikulis, BT, Gottlieb, D, Gerneke, D, LeGrice, I, Padera, RF, Mayer, JE, Schoen, FJ, Sacks, MS. Three‐dimensional quantitative micromorphology of pre‐ and post‐implanted engineered heart valve tissues. Ann Biomed Eng 2011, 39:205–222.
Hoerstrup, S, Kadner, A, Melnitchouk, S, Trojan, A, Eid, K, Tracy, J, Sodian, R, Visjager, JF, Kolb, SA, Grunenfelder, J, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002, 106:143–150.
Sutherland, FW, Perry, TE, Yu, Y, Sherwood, MC, Rabkin, E, Masuda, Y, Garcia, GA, McLellan, DL, Engelmayr, GC Jr, Sacks, MS, et al. From stem cells to viable autologous semilunar heart valve. Circulation 2005, 111:2783–2791.
Syedain, ZH, Tranquillo, RT. Controlled cyclic stretch bioreactor for tissue‐engineered heart valves. Biomaterials 2009, 30:4078–4084.
Zund, G, Breuer, CK, Shinoka, T, Ma, PX, Langer, R, Mayer, JE, Vacanti, JP. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1996, 11:493–497.
Flanagan, TC, Wilkins, B, Black, A, Jockenhoevel, S, Smith, TJ, Pandit, AS. A collagen‐glycosaminoglycan co‐culture model for heart valve tissue engineering applications. Biomaterials 2006, 27:2233–2246.
Uccelli, A, Moretta, L, Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726–736.
Majore, I, Moretti, P, Hass, R, Kasper, C. Identification of subpopulations in mesenchymal stem cell‐like cultures from human umbilical cord. Cell Commun Signal 2009, 7:6.
Sarugaser, R, Hanoun, L, Keating, A, Stanford, W, Davies, JE. Human mesenchymal stem cells self‐renew and differentiate according to a deterministic hierarchy. PLoS One 2009, 4:1–11.
Colazzo, F, Sarathchandra, P, Smolenski, RT, Chester, AH, Tseng, YT, Czernuszka, JT, Yacoub, MH, Taylor, PM. Extracellular matrix production by adipose‐derived stem cells: implications for heart valve tissue engineering. Biomaterials 2011, 32:119–127.
Flanagan, TC, Sachweh, JS, Frese, J, Ing, D, Schnoring, H, Gronioh, N, Koch, S, Toiba, RH, Schmitz‐Rode, T, Jockenhoevel, S. In vivo remodeling and structural characterization of fibrin‐based tissue‐engineered heart valves in the adult sheep model. Tissue Eng Part A 2009, 15:2966–2976.
Syedain, ZH, Lahti, MT, Johnson, SL, Robinson, PS, Ruth, GR, Bianco, RW, Tranquillo, RT. Implantation of a tissue‐engineered heart valve from human fibroblasts exhibiting short term function in the sheep pulmonary artery. Cardiovasc Eng Technol 2011, 2:101–112.
Rajamannan, NM, Evans, FJ, Aikawa, E, Grande‐Allen, KJ, Demer, LL, Heistad, DD, Simmons, CA, Masters, KS, Mathieu, P, O`Brien, KD, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease‐2011 update. Circulation 2011, 124:1783–1791.
Lutolf, MP, Hubbell, JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23:47–55.
Rothenburger, M, Volker, W, Vischer, JP, Berendes, E, Glasmacher, B, Scheld, HH, Deiwick, M. Tissue engineering of heart valves: formation of a three‐dimensional tissue using porcine heart valve cells. ASAIO J 2002, 48:586–591.
Butcher, JT, Penrod, AM, Garcia, AJ, Nerem, RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 2004, 24:1429–1434.
Taylor, PM. Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci 2007, 362:1313–1320.
Tedder, ME, Liao, J, Weed, B, Stabler, C, Zhang, H, Simionescu, A, Simionescu, DT. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A 2009, 15:1258–1270.
Shi, Y. Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum 2002, 38:35–40.
Masters, KS, Shah, DN, Leinwand, LA, Anseth, KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 2005, 26:2517–2525.
Duan, B, Kapetanovic, E, Hockaday, LA, Butcher, JT. Three‐dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta Biomater 2014, 10:1836–1846.
Benton, JA, DeForest, CA, Vivekanandan, V, Anseth, KS. Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A 2009, 15:3221–3229.
Dreger, SATP, Allen, SP, Yacoub, MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPS) in human heart valves. J Heart Valve Dis 2002, 11:875–880.
Sodian, R, Lueders, C, Kraemer, L, Kuebler, W, Shakibaei, M, Reichart, B, Daebritz, S, Hetzer, R. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg 2006, 81:2207–2216.
Ramaswamy, S, Gottlieb, D, Engelmayr, GC Jr, Aikawa, E, Schmidt, DE, Gaitan‐Leon, DM, Sales, VL, Mayer, JE Jr, Sacks, MS. The role of organ level conditioning on the promotion of engineered heart valve tissue development in‐vitro using mesenchymal stem cells. Biomaterials 2010, 31:1114–1125.
Sodian, R. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng 2000, 6:183–188.
Sodian, R, Hoerstrup, SP, Sperling, JS, Martin, DP, Daebritz, S, Mayer, JEJ, Vacanti, JP. Evaluation of biodegradable, three‐dimensional matrices for tissue engineering of heart valves. ASAIO J 2000, 46:107–110.
Del Gaudio, C, Bianco, A, Grigioni, M. Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design. Ann 1st Super Sanita 2008, 44:178–186.
Sales, VL, Engelmayr, GC Jr, Johnson, JA Jr, Gao, J, Wang, Y, Sacks, MS, Mayer, JE Jr. Protein precoating of elastomeric tissue‐engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells. Circulation 2007, 116:I‐55–I‐63.
Sant, S, Hwang, CM, Lee, SH, Khademhosseini, A. Hybrid PGS‐PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen Med 2011, 5:283–291.
Masoumi, N, Annabi, N, Assmann, A, Larson, BL, Hjortnaes, J, Alemdar, N, Kharaziha, M, Manning, KB, Mayer, JE Jr, Khademhosseini, A. Tri‐layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials 2014, 35:7774–7785.
Kalfa, D, Bel, A, Chen‐Tournoux, A, Della Martina, A, Rochereau, P, Coz, C, Bellamy, V, Bensalah, M, Vanneaux, V, Lecourt, S, et al. A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model. Biomaterials 2010, 31:4056–4063.
Benton, JA, Fairbanks, BD, Anseth, KS. Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials 2009, 30:6593–6603.
Anderson, SB, Lin, CC, Kuntzler, DV, Anseth, KS. The performance of human mesenchymal stem cells encapsulated in cell‐degradable polymer‐peptide hydrogels. Biomaterials 2011, 32:3564–3574.
Schmidt, D, Stock, UA, Hoerstrup, SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci 2007, 362:1505–1512.
Bloch, O, Golde, P, Dohmen, PM, Posner, S, Konertz, W, Erdbrugger, W. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves. Tissue Eng Part A 2011, 17:2399–2405.
Frank, BS, Toth, PB, Wells, WK, McFall, CR, Cromwell, ML, Hilbert, SL, Lofland, GK, Hopkins, RA. Determining cell seeding dosages for tissue engineering human pulmonary valves. J Surg Res 2012, 174:39–47.
Syedain, ZH, Bradee, AR, Kren, S, Taylor, DA, Tranquillo, RT. Decellularized tissue‐engineered heart valve leaflets with recellularization potential. Tissue Eng Part A 2013, 19:759–769.
Eslami, M, Vrana, NE, Zorlutuna, P, Sant, S, Jung, S, Masoumi, N, Khavari‐Nejad, RA, Javadi, G, Khademhosseini, A. Fiber‐reinforced hydrogel scaffolds for heart valve tissue engineering. J Biomater Appl 2014, 29:399–410.
Larouche, D, Paquet, C, Fradette, J, Carrier, P, Auger, F, Germain, L. Regeneration of skin and cornea by tissue engineering. In: Audet, J, Stanford, W, eds. Stem Cells in Regenerative Medicine, vol. 482. New York, NY: Humana Press; 2009, 233–256.
L`Heureux, N, Paquet, S, Labbe, R, Germain, L, Auger, FA. A completely biological tissue‐engineered human blood vessel. FASEB J 1998, 12:47–56.
Dube, J, Bourget, JM, Gauvin, R, Lafrance, H, Roberge, CJ, Auger, FA, Germain, L. Progress in developing a living human tissue‐engineered tri‐leaflet heart valve assembled from tissue produced by the self‐assembly approach. Acta Biomater 2014, 10:3563–3570.
Sacks, MS, David Merryman, W, Schmidt, DE. On the biomechanics of heart valve function. J Biomech 2009, 42:1804–1824.
Engelmayr, GC, Hildebrand, DK, Sutherland, FWH, Mayer, JE, Sacks, MS. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials 2003, 24:2523–2532.
Hoerstrup, S, Sodian, R, Sperling, JS, Vacanti, JP, Mayer, JE. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng 2000, 6:75–79.
Sodian, R, Loebe, M, Hein, A, Martin, DP, Hoerstrup, SP, Potapov, EP, Haussman, H, Lueth, T, Hetzer, R. Application of stereolithography for scaffold fabrication for tissue engineered heart valves. ASAIO J 2002, 48:12–16.
Morsi, YS, Yang, WW, Owida, A, Wong, CS. Development of a novel pulsatile bioreactor for tissue culture. J Artif Organs 2007, 10:109–114.
Engelmayr, GC Jr, Soletti, L, Vigmostad, SC, Budilarto, SG, Federspiel, WJ, Chandran, KB, Vorp, DA, Sacks, MS. A novel flex‐stretch‐flow bioreactor for the study of engineered heart valve tissue mechanobiology. Ann Biomed Eng 2008, 36:700–712.
Boerboom, RA, Rubbens, MP, Driessen, NJ, Bouten, CV, Baaijens, FP. Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng 2008, 36:244–253.
Rubbens, MP, Mol, A, Boerboom, RA, Bank, RA, Baaijens, FP, Bouten, CV. Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue. Tissue Eng Part A 2009, 15:999–1009.
Mol, A, Smits, AI, Bouten, CV, Baaijens, FP. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 2009, 6:259–275.
Emmert, MY, Weber, B, Wolint, P, Behr, L, Sammut, S, Frauenfelder, T, Frese, L, Scherman, J, Brokopp, CE, Templin, C, et al. Stem cell‐based transcatheter aortic valve implantation: first experiences in a pre‐clinical model. JACC Cardiovasc Interv 2012, 5:874–883.
Weber, B, Scherman, J, Emmert, MY, Gruenenfelder, J, Verbeek, R, Bracher, M, Black, M, Kortsmit, J, Franz, T, Schoenauer, R, et al. Injectable living marrow stromal cell‐based autologous tissue engineered heart valves: first experiences with a one‐step intervention in primates. Eur Heart J 2011, 32:2830–2840.
Riem Vis, PW, Kluin, J, Sluijter, JP, van Herwerden, LA, Bouten, CV. Environmental regulation of valvulogenesis: implications for tissue engineering. Eur J Cardiothorac Surg 2011, 39:8–17.
Narine, K, Wever, OD, Valckenborgh, DV, Francois, K, Bracke, M, Desmet, S, Mareel, M, Nooten, GV. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng 2006, 12:2707–2716.
Merryman, WD, Liao, J, Parekh, A, Candiello, JE, Lin, H, Sacks, MS. Differences in tissue‐remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng 2007, 13:2281–2289.
Huang, SD, Liu, XH, Bai, CG, Lu, FL, Yuan, Y, Gong, DJ, Xu, ZY. Synergistic effect of fibronectin and hepatocyte growth factor on stable cell‐matrix adhesion, re‐endothelialization, and reconstitution in developing tissue‐engineered heart valves. Heart Vessels 2007, 22:116–122.
Cushing, MC, Mariner, PD, Liao, JT, Sims, EA, Anseth, KS. Fibroblast growth factor represses Smad‐mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008, 22:1769–1777.
Iwamoto, R, Mekada, E. ErbB and HB‐EGF signaling in heart development and function. Cell Struct Funct 2006, 31:1–14.
Dor, Y, Klewer, SE, McDonald, JA, Keshet, E, Camenisch, TD. VEGF modulates early heart valve formation. Anat Rec A Discov Mol Cell Evol Biol 2003, 271:202–208.
Duan, B, Hockaday, LA, Das, S, Xu, C, Butcher, JT. Comparison of mesenchymal stem cell source differentiation toward human pediatric aortic valve interstitial cells within 3D engineered matrices. Tissue Eng Part C Methods 2015, 21:1–13.
Van Vlimmeren, MA, Mol, A, van den Broek, M, Bouten, CV, Baaijens, FP. Controlling matrix formation and cross‐linking by hypoxia in cardiovascular tissue engineering. J Appl Physiol 2010, 109:1483–1491.
Ma, T, Grayson, WL, Frohlich, M, Vunjak‐Novakovic, G. Hypoxia and stem cell‐based engineering of mesenchymal tissues. Biotechnol Prog 2009, 25:32–42.
Lueders, C, Jastram, B, Hetzer, R, Schwandt, H. Rapid manufacturing techniques for the tissue engineering of human heart valves. Eur J Cardiothorac Surg 2014, 46:593–601.
Tseng, H, Cuchiara, ML, Durst, CA, Cuchiara, MP, Lin, CJ, West, JL, Grande‐Allen, KJ. Fabrication and mechanical evaluation of anatomically‐inspired quasilaminate hydrogel structures with layer‐specific formulations. Ann Biomed Eng 2013, 41:398–407.
Alavi, SH, Kheradvar, A. A hybrid tissue‐engineered heart valve. Ann Thorac Surg 2015, 99:2183–2187.
Hinton, RB, Yutzey, KE. Heart valve structure and function in development and disease. Annu Rev Physiol 2011, 73:29–46.
Engler, AJ, Sen, S, Sweeney, HL, Discher, DE. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677–689.
Kloxin, AM, Benton, JA, Anseth, KS. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010, 31:1–8.
Chen, JH, Chen, WL, Sider, KL, Yip, CY, Simmons, CA. β‐Catenin mediates mechanically regulated, transforming growth factor‐β1‐induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 2011, 31:590–597.
Yip, CY, Chen, JH, Zhao, R, Simmons, CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009, 29:936–942.
Pho, M, Lee, W, Watt, DR, Laschinger, C, Simmons, CA, McCulloch, CA. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008, 294:H1767–H1778.
Cushing, MC, Liao, JT, Jaeggli, MP, Anseth, KS. Material‐based regulation of the myofibroblast phenotype. Biomaterials 2007, 28:3378–3387.
Rodriguez, KJ, Masters, KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A 2009, 90:1043–1053.
Gu, X, Masters, KS. Regulation of valvular interstitial cell calcification by adhesive peptide sequences. J Biomed Mater Res A 2010, 94:1620–1630.
Gould, ST, Darling, NJ, Anseth, KS. Small peptide functionalized thiol‐ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition. Acta Biomater 2012, 8:3201–3209.
Balachandran, K, Sucosky, P, Jo, H, Yoganathan, AP. Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease. Am J Physiol Heart Circ Physiol 2009, 296:H756–H764.
Moraes, C, Likhitpanichkul, M, Lam, CJ, Beca, BM, Sun, Y, Simmons, CA. Microdevice array‐based identification of distinct mechanobiological response profiles in layer‐specific valve interstitial cells. Integr Biol (Camb) 2013, 5:673–680.
Waxman, AS, Kornreich, BG, Gould, RA, Moise, NS, Butcher, JT. Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture. J Vet Cardiol 2012, 14:211–221.
Janes, KA, Yaffe, MB. Data‐driven modelling of signal‐transduction networks. Nat Rev Mol Cell Biol 2006, 7:820–828.
Cosgrove, B, Griffith, L, Lauffenburger, D. Fusing tissue engineering and systems biology toward fulfilling their promise. Cell Mol Bioeng 2008, 1:33–41.
Janes, KA, Albeck, JG, Gaudet, S, Sorger, PK, Lauffenburger, DA, Yaffe, MB. A systems model of signaling identifies a molecular basis set for cytokine‐induced apoptosis. Science 2005, 310:1646–1653.
Lau, KS, Cortez‐Retamozo, V, Philips, SR, Pittet, MJ, Lauffenburger, DA, Haigis, KM. Multi‐scale in vivo systems analysis reveals the influence of immune cells on TNF‐α‐induced apoptosis in the intestinal epithelium. PLoS Biol 2012, 10:e1001393.
Sider, KL, Blaser, MC, Simmons, CA. Animal models of calcific aortic valve disease. Int J Inflam 2011, 2011:364310.
Esch, EW, Bahinski, A, Huh, D. Organs‐on‐chips at the frontiers of drug discovery. Nat Rev Drug Discov 2015, 14:248–260.
Flaim, CJ, Chien, S, Bhatia, SN. An extracellular matrix microarray for probing cellular differentiation. Nat Methods 2005, 2:119–125.
Gobaa, S, Hoehnel, S, Roccio, M, Negro, A, Kobel, S, Lutolf, MP. Artificial niche microarrays for probing single stem cell fate in high throughput. Nat Methods 2011, 8:949–955.
Dolatshahi‐Pirouz, A, Nikkhah, M, Gaharwar, AK, Hashmi, B, Guermani, E, Aliabadi, H, Camci‐Unal, G, Ferrante, T, Foss, M, Ingber, DE, et al. A combinatorial cell‐laden gel microarray for inducing osteogenic differentiation of human mesenchymal stem cells. Sci Rep 2014, 4:3896.
Liu, H, Usprech, J, Sun, Y, Simmons, CA. A microfabricated platform with hydrogel arrays for 3D mechanical stimulation of cells. Acta Biomater 2015. doi:10.1016/j.actbio.2015.11.054. (Epub ahead of print; November 29, 2015).
Moraes, C, Chen, J‐H, Sun, Y, Simmons, CA. Microfabricated arrays for high‐throughput screening of cellular response to cyclic substrate deformation. Lab Chip 2010, 10:227–234.
Theodoris, CV, Li, M, White, MP, Liu, L, He, D, Pollard, KS, Bruneau, BG, Srivastava, D. Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. Cell 2015, 160:1072–1086.